System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment
PFV is the FDA product code for System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment, a class III device type. FDA's definition for this code reads: "An endovascular graft for AV dialysis access is a stent graft intended for the revision of arteriovenous access circuits to maintain or re-establish vascular access (treat stenotic lesions or thromboic occlusions) for hemodialysis". As of , FDA records hold no 510(k) clearances under this code and one recall.
Classification record
- Product code
- PFV
- Device name
- System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment
- FDA definition
- An endovascular graft for AV dialysis access is a stent graft intended for the revision of arteriovenous access circuits to maintain or re-establish vascular access (treat stenotic lesions or thromboic occlusions) for hemodialysis.
- Device class
- Class III
- Review panel
- Unknown
- Submission type
- PMA
- Implant
- Yes
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 0
- Ingested recalls
- 1
Companies listing this code with FDA
Companies whose registered establishments list this code- Angiomed GmbH & Co. Medizintechnik KG
- Bard European Distribution Center NV
- Bard Peripheral Vascular Inc
- Merit Medical Asia Company Limited
- Merit Medical Australia Pty Ltd.
- Merit Medical Canada Ltd.
- Merit Medical Nederland BV
- Merit Medical Systems, Inc.
- Merit Medical UK Limited
- Sterigenics Belgium (Petit Rechain) SRL
- Sterigenics Germany GmbH
- Sterigenics U.S., LLC
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
